Search for: "AstraZeneca UK Ltd."
Results 21 - 40
of 82
Sort by Relevance
|
Sort by Date
30 Nov 2012, 7:45 am
Astrazeneca UK Ltd., et al. v. [read post]
23 Oct 2012, 12:34 pm
AstraZeneca UK Ltd., 628 F.3d 643 (4th Cir. 2010). [read post]
23 Mar 2012, 4:00 am
& Anor [2012] EWHC 716 (Ch) (22 March 2012) Rohl v Bickland Ltd [2012] EWHC 706 (Ch) (22 March 2012) High Court (Patents Court) Teva UK Ltd & Ors v Astrazeneca AB [2012] EWHC 655 (Pat) (22 March 2012) Regeneron Pharmacueticals Inc v Genentech Inc [2012] EWHC 657 (Pat) (22 March 2012) Source: www.bailii.org [read post]
13 Feb 2012, 12:54 pm
RE37,314 directed to novel compounds that inhibit the biosynthesis of cholesterol, including the active ingredient in CRESTOR®: "a cation capable of forming a non-toxic pharmaceutically acceptable salt" AstraZeneca UK Ltd. v. [read post]
15 Dec 2011, 2:51 am
Court of Appeal (Criminal Division) RO, R. v [2011] EWCA Crim 2910 (22 November 2011) Court of Appeal (Civil Division) Rahmatullah v Secretary of State for Foreign & Commonwealth Affairs & Anor [2011] EWCA Civ 1540 (14 December 2011) Spaceright Europe Ltd v Baillavoine & Anor [2011] EWCA Civ 1565 (14 December 2011) High Court (Queen’s Bench Division) Norman v Cheshire Fire & Rescue Service [2011] EWHC 3305 (QB) (14 December 2011) High Court (Administrative… [read post]
5 Dec 2011, 9:59 pm
In Ranbaxy (UK) Ltd v AstraZeneca AB, the England and Wales High Court considered the scope of "Swiss" medical use claims. [read post]
23 Nov 2011, 2:06 am
Court of Appeal (Civil Division) Mousa, R (on the application of) v Secretary of State for Defence & Anor [2011] EWCA Civ 1334 (22 November 2011) Chaudhary v Yavuz [2011] EWCA Civ 1314 (22 November 2011) London Tara Hotel Ltd v Kensington Close Hotel Ltd [2011] EWCA Civ 1356 (22 November 2011) High Court (Administrative Court) AS v London Borough of Croydon [2011] EWHC 2091 (Admin) (25 October 2011) High Court (Chancery Division) Secretary of State for Business, Innovation… [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Orange Book Blog) (IP Watch) (KEI) (Patent Docs) (Patent Docs) (IP Spotlight) (Patently-O) (Inventive Step) (Patentology) (Patent Law Practice Center) (IPBiz) (Out-Law) (PharmaPatents) (Maier & Maier) (Patent Docs) (Patent Baristas) Memantine – EU: CJEU ruling rejects pre-65/65 authorisations: Case C-195/09 Synthon v Merz Pharma (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon Inc,… [read post]
19 Jul 2011, 2:49 am
Supreme Court Duncombe & Ors v Secretary of State for Children, Schools and Families [2011] UKSC 36 (15 July 2011) High Court (Patents Court) Ranbaxy (UK) Ltd v Astrazeneca AB [2011] EWHC 1831 (Pat) (15 July 2011) Select Healthcare (UK) Ltd v Cromptons Healthcare Ltd & Anor [2011] EWHC 1830 (Pat) (15 July 2011) Source: www.bailii.org [read post]
16 Jul 2011, 1:42 am
Ranbaxy (UK) Ltd. v AstraZeneca AB [2011] EWHC 1831 (Pat) (15 July 2011) raises an interesting point on the interpretation of claims. [read post]
21 Jun 2011, 2:33 am
& Ors, Re [2011] EWHC 1565 (Ch) (02 June 2011) Sunwing Vacation Inc & Ors v E-Clear (UK) Plc & Ors [2011] EWHC 1544 (Ch) (03 June 2011) High Court (Queen’s Bench Division) Caplin v Associated Newspapers Ltd [2011] EWHC 1567 (QB) (20 June 2011) BB & Ors v The Home Office [2011] EWHC 1446 (QB) (08 June 2011) High Court (Commercial Court) Yukos Capital SARL v OJSC Rosneft Oil Company [2011] EWHC 1461 (Comm) (14 June 2011) Astrazeneca UK… [read post]
27 Apr 2011, 4:55 am
(IP Watch) China: Pfizer starts R&D in China after IPR in China challenges (IP Dragon) UK: IPO inviting comment on C-630/10 University of Queensland, CSL Ltd v Comptroller-General of Patents, Designs and Trade Marks and C-130/11 Neurim v Comptroller General of Patents (The SPC Blog) (The SPC Blog) US: New generics quickly grab 80% of sales volume (GenericsWeb) Products Actos (Pioglitazone) – US: Takeda agrees to dismiss one Actos infringement suit against Apotex (Patent… [read post]
15 Feb 2011, 5:26 pm
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) – US: Watson… [read post]
12 Jan 2011, 2:22 pm
AstraZeneca UK Ltd. [read post]
22 Dec 2010, 3:01 am
Aurobindo Pharma Ltd. et al. [read post]
8 Dec 2010, 11:13 am
AstraZeneca UK Ltd. that it was required to interpret the forum selection clause negotiated by the parties under English law, which meant that the clause would be read as requiring litigation to be brought in an English court, even though the clause would have been deemed permissive under American law and would have allowed the lawsuit at issue to be filed in the South Carolina court where it had in fact been filed. [read post]
8 Dec 2010, 2:20 am
Allergan, Inc (Docket Report) Products Enbrel (Etanercept) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Fabrazyme (Alpha-galactosidase) – US: Statements by KEI and others on NIH rejection of Fabrazyme march-in request (KEI) Intuniv (Guanfacine) – US: Impax confirms patent challenge relating to Intuniv (GenericsWeb) Lovenox (Enoxaparin) – US: Momenta sues Teva over claims relating to ways of manufacturing and analysing structure… [read post]
17 Nov 2010, 1:48 am
Highlights this week included: Efexor (Venlafaxine) – Australia: Federal Court blocks generic Efexor-XR: Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth Australia Pty Ltd (Patentology) (BAZPAT) (GenericsWeb) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
14 Nov 2010, 8:48 pm
Astrazeneca UK Ltd. et al. v. [read post]
25 Aug 2010, 12:37 am
Torrent Pharmaceuticals Ltd. et al. [read post]
